Based on the Global Proteome Machine Database, the tool helps with identification of genomic variants that affect protein post-translational modification sites.
The Swedish firm, a spinout of Lund University, will evaluate the array-based blood tests to confirm, rule out, and monitor the autoimmune disease.
The company aims to enroll 3,000 women in the registry, which it plans to use for research and development of tests to detect and manage pelvic masses.
The company reported Q4 revenues of $478.2 million and organic revenue growth of nearly 3 percent as currency effects negatively impacted revenues by 8 percent.
The effort combined methods including front-end electron transfer dissociation with ion/ion proton transfer and ion parking to study H2A and H2B proteoforms.
In Nature this week: weighting scheme increases GWAS power, and more.
Marc Tessier-Lavigne is to be the next president of Stanford University.
Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.
Journals and research funding agencies pledge to enable the sharing of Zika virus research.